Published in
American Association for the Advancement of Science, Science Advances, 1(7), 2021
Links
Tools
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
Journal article published in 2020 by
Justin Stebbing 
,
Ginés Sánchez Nievas ,
Marco Falcone,
Sonia Youhanna ,
Peter Richardson,
Silvia Ottaviani ,
Joanne X. Shen,
Christian Sommerauer ,
Giusy Tiseo,
Lorenzo Ghiadoni,
Agostino Virdis,
Fabio Monzani ,
Luis Romero Rizos,
Francesco Forfori ,
Almudena Avendaño-Céspedes
and other authors.
,
Ginés Sánchez Nievas ,
Marco Falcone,
Sonia Youhanna ,
Peter Richardson,
Silvia Ottaviani ,
Joanne X. Shen,
Christian Sommerauer ,
Giusy Tiseo,
Lorenzo Ghiadoni,
Agostino Virdis,
Fabio Monzani ,
Luis Romero Rizos,
Francesco Forfori ,
Almudena Avendaño-Céspedes
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 
Abstract
The dual anticytokine and antiviral actions of baricitinib reduce SARS-CoV-2 infectivity in organoids and morbidity in people.